Dr Suresh Jadhav, executive director of the Serum Institute of India, told The Indian Express that India is heading fast towards vaccine development, as two manufacturers are already in phase-3 trial and one in the phase-2 trial, and more players are joining ? Read More

reported by Anuradha Mascarenhas at The Indian Express